Literature DB >> 22108033

Peripheral immunization induces functional intrahepatic hepatitis C specific immunity following selective retention of vaccine-specific CD8 T cells by the liver.

Krystle A Lang Kuhs1, Roberta Toporovski, Arielle A Ginsberg, Abby L Olsen, Devon J Shedlock, Matthew P Morrow, Jian Yan, Rebecca G Wells, David B Weiner.   

Abstract

It is believed that an effective HCV vaccine must induce strong HCV-specific cytotoxic IFN-γ⁺ CD8⁺ T cells able to migrate into and become fully activated within the liver, an organ known to suppress T cell responses and induce tolerance. Given the importance of intrahepatic HCV-specific T cells in the clearance of acute infection, the goal of this present study was to determine if peripheral immunization was able to induce functional intrahepatic HCV-specific T cell based immunity both in the presence and absence of HCV antigen expression within the liver. Using a novel HCV NS3/NS4A DNA vaccine, we show that peripheral immunization of C57BL/6 mice results in the formation of a large pool of fully functional HCV-specific cytotoxic IFN-γ⁺ CD8⁺ T cells within the liver and that these cells were highly enriched within the liver as compared to the spleen. Following hepatic expression of cognate HCV antigen using a previously described liver transfection method, we show that this pool of vaccine-induced HCV-specific CD8⁺ T cells retained its ability to become highly activated as shown by the upregulation of IFN-γ and CCR5 expression, as well as by the clearance of HCV NS3 expressing hepatocytes. Taken together, these findings suggest that T cell effector function is preserved within the liver and that selective recruitment of antigen-specific T cells to the liver may play a previously unappreciated role in the process of immune surveillance, which may be exploited for future T cell based HCV vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108033      PMCID: PMC3338931          DOI: 10.4161/hv.7.12.18279

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  26 in total

1.  Selective retention of activated CD8+ T cells by the normal liver.

Authors:  W Z Mehal; A E Juedes; I N Crispe
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

2.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

Authors:  G Zhang; V Budker; J A Wolff
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

3.  Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation.

Authors:  S Qian; L Lu; Y Li; F Fu; W Li; T E Starzl; A W Thomson; J J Fung
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

Review 4.  Adaptive immune responses in acute and chronic hepatitis C virus infection.

Authors:  David G Bowen; Christopher M Walker
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

5.  Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

Authors:  X Zhang; S Sun; I Hwang; D F Tough; J Sprent
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

6.  The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo.

Authors:  L Huang; G Soldevila; M Leeker; R Flavell; I N Crispe
Journal:  Immunity       Date:  1994-12       Impact factor: 31.745

7.  The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.

Authors:  David G Bowen; Monica Zen; Lauren Holz; Thomas Davis; Geoffrey W McCaughan; Patrick Bertolino
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis.

Authors:  S C Afford; N C Fisher; D A Neil; J Fear; P Brun; S G Hubscher; D H Adams
Journal:  J Pathol       Date:  1998-09       Impact factor: 7.996

9.  Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage.

Authors:  R M Gorczynski; Z Chan; S Chung; Z Cohen; G Levy; B Sullivan; X M Fu
Journal:  Transplantation       Date:  1994-10-15       Impact factor: 4.939

10.  Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.

Authors:  Naglaa H Shoukry; Arash Grakoui; Michael Houghton; David Y Chien; John Ghrayeb; Keith A Reimann; Christopher M Walker
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more
  6 in total

1.  Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.

Authors:  Brian Latimer; Roberta Toporovski; Jian Yan; Panyupa Pankhong; Matthew P Morrow; Amir S Khan; Niranjan Y Sardesai; Seth L Welles; Jeffrey M Jacobson; David B Weiner; Michele A Kutzler
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Dendritic cell-based immunity and vaccination against hepatitis C virus infection.

Authors:  Yun Zhou; Ying Zhang; Zhiqiang Yao; Jonathan Patrick Moorman; Zhansheng Jia
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

3.  Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.

Authors:  Hyojin Lee; Moonsup Jeong; Jooyeon Oh; Youngran Cho; Xuefei Shen; John Stone; Jian Yan; Zachary Rothkopf; Amir S Khan; Byung Mun Cho; Young K Park; David B Weiner; Woo-Chan Son; Joel N Maslow
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

4.  HCV p7 as a novel vaccine-target inducing multifunctional CD4+ and CD8+ T-cells targeting liver cells expressing the viral antigen.

Authors:  Jonathan Filskov; Peter Andersen; Else Marie Agger; Jens Bukh
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

5.  A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice.

Authors:  Reham M Dawood; Rehab I Moustafa; Tawfeek H Abdelhafez; Reem El-Shenawy; Yasmine El-Abd; Noha G Bader El Din; Jean Dubuisson; Mostafa K El Awady
Journal:  BMC Infect Dis       Date:  2019-11-05       Impact factor: 3.090

6.  Induction of intrahepatic HCV NS4B, NS5A and NS5B-specific cellular immune responses following peripheral immunization.

Authors:  Krystle A Lang Kuhs; Roberta Toporovski; Jian Yan; Arielle A Ginsberg; Devon J Shedlock; David B Weiner
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.